Chr. Hansen and Lonza joint venture: Ready for contract manufacturing
Chr. Hansen Holding, a global bioscience company, and Lonza AG, a pharma contract manufacturing company, have announced that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint venture in the emerging m
2022-04-15 ·
nutraceuticalbusinessreview